Zee Hwan Lee

Title: Zee Hwan Lee: Innovator in Pharmaceutical Composition

Introduction

Zee Hwan Lee is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the area of pain management related to cancer treatment. His innovative work focuses on alleviating the side effects of anticancer agents.

Latest Patents

Zee Hwan Lee holds a patent for a pharmaceutical composition aimed at preventing or treating allodynia caused by anticancer agents. The patent describes a composition that includes cinnamic acid or a pharmaceutically acceptable salt thereof as an active ingredient. This composition can be administered to patients scheduled to receive anticancer agents or those who have already undergone such treatments, providing relief from the painful side effects associated with these therapies.

Career Highlights

Zee Hwan Lee is affiliated with the University-Industry Cooperation Group of Kyung Hee University. His role in this group allows him to bridge the gap between academic research and practical applications in the pharmaceutical industry. His work is characterized by a commitment to improving patient outcomes through innovative solutions.

Collaborations

Zee Hwan Lee collaborates with esteemed colleagues, including Sun Kwang Kim and Dae Sik Jang. These partnerships enhance the research and development process, fostering an environment of innovation and shared expertise.

Conclusion

Zee Hwan Lee's contributions to pharmaceutical science, particularly in addressing the challenges of allodynia in cancer patients, highlight his role as a key innovator in the field. His work exemplifies the importance of research in improving the quality of life for individuals undergoing cancer treatment.